[Splenic lymphoma of Ki-1 positive B-cell type treated with CHOP]

T Terashima1, K Tominaga, M Tuji

  • 1Department of Internal Medicine, Social Insurance Saitama Chuo Hospital.

Insights

A rare B-cell Ki-1 lymphoma case presenting with lymphadenopathy and splenomegaly achieved complete remission with CHOP chemotherapy. This study discusses the pathological and clinical features of this specific lymphoma subtype.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Ki-1 lymphoma, a rare subtype, presents diagnostic challenges.
  • B-cell lymphomas require precise pathological identification for effective treatment.

Observation:

  • A 75-year-old male presented with supraclavicular and cervical lymphadenopathy, and splenomegaly.
  • CT scan revealed paraaortic lymphadenopathy and splenic lesions.
  • Biopsy confirmed Ki-1 lymphoma with characteristic large cells positive for IgM, lambda, CD20, and CD30 (Ki-1).

Findings:

  • The spleen was suspected as the primary lymphoma site based on imaging.
  • The patient achieved complete remission following systemic chemotherapy using the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone).

Implications:

  • This case highlights the importance of thorough pathological and radiological evaluation for diagnosing Ki-1 lymphoma.
  • Successful treatment with CHOP chemotherapy suggests its efficacy in managing this B-cell lymphoma variant.
  • Further research into the specific characteristics and optimal management of B-cell Ki-1 lymphoma is warranted.

Related Concept Videos